According to a research report titled ‘Global Prepacked Chromatography Columns Market by Type (1-100 mL, 100-1000 mL, >1L), Regional Forecasts 2021-2027’, available with Market Study Report, global prepacked chromatography columns market was worth USD 2.4 billion in 2020 and is expected to attain a valuation of USD 4.2 billion over 2021-2027, registering a CAGR of 8.4% throughout.
 

As per the report findings, significant international collaborations between leading food and drug development companies, research institutes and beverage analysis laboratories is stimulating worldwide prepacked chromatography columns industry growth. Additionally, mounting demand for biopharmaceutical products, and augmenting R&D activities in analytical departments of biotechnology and pharmaceutical sectors are creating a positive outlook for the market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3930310/
 

Statista reported that France spent approximately USD 4 billion on biotechnology sector research and development in 2019, followed by Switzerland, which expended about USD 3.9 billion.
 

Furthermore, increasing number of drug discovery applications, along with heavy investments on novel molecules in nutraceuticals are offering new opportunities for businesses operating in this domain.
 

For the record, chromatography is a method used to isolate specific chemical compounds from a mixture of chemicals. The pre-filled columns used in testing techniques are termed pre-packed chromatography columns.
 

Elaborating on the negatives, technological constraints for column sizes is likely to hamper market growth in the upcoming years.
 

Moving on to geographical scope, North America currently holds a majority share in worldwide prepacked chromatography columns market due to strong presence of several leading pharmaceutical and biotechnology companies, as well as availability of advanced R&D infrastructure across the region.
 

Meanwhile, Asia Pacific industry is estimated to grow at a substantial pace during the forecast period 2021-2027. This can be ascribed to surging requirements for antibody purification and separation of recombinant vaccines and proteins, alongside advancements of process chromatography technologies in pharmaceutical and agriculture industries in the region.
 

Lastly, the report incorporates business profiles of prominent market players like Shimadzu Corp., Knauer Wissenschaftliche Geräte GmbH, MilliporeSigma (Merck KGaA), Danaher Corp., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Repligen Corp., and GE Healthcare.